KROS
Keros Therapeutics, Inc. · Healthcare
Director and 10% owner Ran Nussbaum bought $3.0M of Keros Therapeutics, Inc.
Bought$3,000,000
$50.00Price
60,000Shares
+63%Stake
What KROS did for a copier
Prices for KROS after this filing aren't in yet.
Ran Nussbaum's record
7 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Nov 17. Filed Thu, Nov 19, 11:40 AM ET, during the session. Not investment advice.